Objectives: To contribute to the policy discussion of equity and health financing in Chile by evaluating the improvement in the capitation formula for paying PHC providers by using selected diagnoses. The socio-economic status of the municipalities and the urban/rural location of providers are...

Objectives: To contribute to the policy discussion of equity and health financing in Chile by evaluating the improvement in the capitation formula for paying PHC providers by using selected diagnoses. The socio-economic status of the municipalities and the urban/rural location of providers are...

Objectives: To contribute to the policy discussion of equity and health financing in Chile by evaluating the improvement in the capitation formula for paying PHC providers by using selected diagnoses. The socio-economic status of the municipalities and the urban/rural location of providers are...

Pharmaceutical products have contributed to longer life expectancy and better quality of life in Latin America and the Caribbean. However, they often account for a significant share of household expenditures, especially among the poor and those facing catastrophic health shocks. And they are not...

Peru reduced its HIV/AIDS burden by 43 percent from 2000 to 2010 due to the introduction of free antiretroviral drug therapy in 2004, and the successful execution of the 2007-2011 HIV/AIDS Strategy and budgeting for results since 2011. The national HIV program received significant external...

Objectives: The prevalence of newborn hearing disorders is 1-3 per 1,000. Crucial for later outcome are correct diagnosis and effective treatment as soon as possible. With BERA and TEOAE low-risk techniques for early detection are available. Universal screening is recommended but not realised in...

In 1996 free choice of health insurers has been introduced in the German social health insurance scheme. Competition between insurers was supposed to increase efficiency. A crucial precondition for effective competition among health insurers is that consumers search for lower-priced health...

This paper examines effects of reference pricing for prescription drugs in German social health insurance based on econometric panel data methods. We analyze the effect on ex-factory prices. Moreover, we investigate whether manufacturers adapt prices of their products not subject to reference...